Press "Enter" to skip to content

New patent for Osmotica Pharm drug OSMOLEX ER

0
Copyright © DrugPatentWatch. Originally published at New patent for Osmotica Pharm drug OSMOLEX ER

Annual Drug Patent Expirations for OSMOLEX+ER
Annual Drug Patent Expirations for OSMOLEX+ER

Osmolex Er is a drug marketed by Osmotica Pharm and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

Drug patent litigation for OSMOLEX ER.

This drug has twenty-nine patent family members in fourteen countries.

The generic ingredient in OSMOLEX ER is amantadine hydrochloride. One supplier is listed for this compound. Additional details are available on the amantadine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Osmotica Pharm drug OSMOLEX ER
Do NOT follow this link or you will be banned from the site!